William S. White
Directeur des opérations chez Nemucore Medical Innovations, Inc.
Profil
William S.
White is currently the Chief Operating Officer at Nemucore Medical Innovations, Inc. He previously served as the Chief Executive Officer & Director at Icon Bioscience, Inc. and Biocache Pharmaceuticals, Inc. He also held positions as Director at The Virginia Biotechnology Research Park and CropTech Corp.
Additionally, he served as Director at Nemucore Medical Innovations, Inc., President at Monsanto Co., and Vice President-Research & Development at Storz Ophthalmics, Inc.
Postes actifs de William S. White
| Sociétés | Poste | Début |
|---|---|---|
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Directeur des opérations | - |
Anciens postes connus de William S. White
| Sociétés | Poste | Fin |
|---|---|---|
| Biocache Pharmaceuticals, Inc. | Directeur Général | - |
The Virginia Biotechnology Research Park
 The Virginia Biotechnology Research Park Real Estate DevelopmentFinance The Virginia Biotechnology Research Park operates a pharmaceutical and biotechnology corridor. The private company is based in Richmond, VA. Chandra Briggman has been the CEO of the company since 2020. | Directeur/Membre du Conseil | - |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Directeur/Membre du Conseil | - |
| CropTech Corp. | Président | - |
| MONSANTO | President | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Icon Bioscience, Inc.
 Icon Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Icon Bioscience, Inc. develops and markets ophthalmic pharmaceuticals. It develops specialty pharmaceuticals targeting ophthalmic indications including macular edema, glaucoma, age-related macular degeneration and cataract surgery. The firm's pipeline includes IBI-10090, IBI-20089, IBI-60089, and IBI-80090. The company was founded by Vernon G. Wong and is headquartered in Newark, CA. | Health Technology |
| Storz Ophthalmics, Inc. | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| CropTech Corp. | |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
| Biocache Pharmaceuticals, Inc. | |
The Virginia Biotechnology Research Park
The Virginia Biotechnology Research Park Real Estate DevelopmentFinance The Virginia Biotechnology Research Park operates a pharmaceutical and biotechnology corridor. The private company is based in Richmond, VA. Chandra Briggman has been the CEO of the company since 2020. | Finance |
